$ICPT News U.S. stocks end lower; Dow turns ne
Post# of 74540
Posted On: 08/25/2014 11:42:52 AM
$ICPT News
U.S. stocks end lower; Dow turns negative for the year 4:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 11:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 8:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 1:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 4:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 7:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 2:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 11:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 1:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 11:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 11:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 10:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 8:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 5:29 p.m. Jan. 10, 2014 - Sue Chang
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update 10:34 a.m. Aug. 23, 2014 - Seeking Alpha
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside 12:01 p.m. Aug. 22, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 8/18/14 6:18 a.m. Aug. 19, 2014 - Seeking Alpha
Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News 1:00 p.m. Aug. 14, 2014 - Zacks.com
Intercept Pharmaceuticals Inc Stock Upgraded (ICPT) 11:12 a.m. Aug. 14, 2014 - TheStreet.com
Perilous Reversal Watch: Intercept Pharmaceuticals (ICPT) 9:58 a.m. Aug. 14, 2014 - TheStreet.com
Analysts' Actions: Cree, Intercept Pharma, Intermune, Tivo 7:39 a.m. Aug. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog 10:40 a.m. Aug. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Worth Watching: Stock Gains 16.6% - Tale of the Tape 9:25 a.m. Aug. 13, 2014 - Zacks.com
'Fast Money' Recap: Stick With U.S. Stocks 5:00 a.m. Aug. 13, 2014 - TheStreet.com
U.S. Stocks End Lower 5:32 p.m. Aug. 12, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Russian Sanctions and Oil in Focus 8/12/14 - Stocks in the News 3:33 p.m. Aug. 12, 2014 - Zacks.com
Intercept Pharma (ICPT) Shares Soar on Liver Disease Drug News - Stocks in the News 2:40 p.m. Aug. 12, 2014 - Zacks.com
Why Intercept Pharmaceuticals (ICPT) Stock Is Skyrocketing Today 12:54 p.m. Aug. 12, 2014 - InvestorPlace.com
Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential 12:27 p.m. Aug. 12, 2014 - Seeking Alpha
Today's Market: New, Disputes And Earnings Impacting These Names 10:55 a.m. Aug. 12, 2014 - Seeking Alpha
Jim Cramer's Mad Dash: The Fed Is Overlooking Biotech Growth 10:39 a.m. Aug. 12, 2014 - TheStreet.com
Intercept Pharma Soars On Liver-Disease Drug Data 9:48 a.m. Aug. 12, 2014 - Investors Business Daily
Why Intercept Pharmaceuticals (ICPT) Stock Is Spiking In Pre-Market Trading Today 9:05 a.m. Aug. 12, 2014 - TheStreet.com
Conatus Shares Move Higher On Industry Data 8:11 a.m. Aug. 12, 2014 - benzinga.com
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 9:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 9:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 5:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 10:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 10:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 9:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 11:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 10:21 a.m. May 13, 2014 - ACCESSWIRE
Earnings Results, Agreements, Study Results, FDA Approvals, and Drug Trial Results - Analyst Notes on Merck, Johnson & Johnson, GlaxoSmithKline, Novartis and Intercept 8:00 a.m. May 12, 2014 - PR Newswire - PRF
Intercept Reports Additional Positive OCA Data in Patients With Bile Acid Diarrhea at Digestive Disease Week 4:06 p.m. May 6, 2014 - GlobeNewswire
Intercept to Host First Quarter 2014 Update on May 7 and Present at Upcoming Investor Conferences 6:06 a.m. May 1, 2014 - GlobeNewswire
Intercept Pharmaceuticals Appoints Rachel McMinn, Ph.D. as Chief Strategy Officer 4:50 p.m. April 30, 2014 - GlobeNewswire
Stock Price Movements, Updates on Clinical Studies, Financial Results Releases, and Company Response to New Laws - Analyst Notes on Perrigo, GlaxoSmithKline, Intercept, Centene and Lorillard 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept 8:00 a.m. April 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- ICPT 4:01 a.m. April 14, 2014 - GlobeNewswire
Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session 12:00 p.m. April 12, 2014 - GlobeNewswire
Intercept Announces Preclinical Data Demonstrating OCA's Potential Role in Preventing Complications of Cirrhosis 9:04 a.m. April 11, 2014 - GlobeNewswire
UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against INTERCEPT PHARMACEUTICALS, INC. and Its Board of Directors and a Lead Plaintiff Deadline of April 22, 2014 -- ICPT 11:48 a.m. April 10, 2014 - GlobeNewswire
U.S. stocks end lower; Dow turns negative for the year 4:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 11:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 8:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 1:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 4:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 7:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 2:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 11:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 1:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 11:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 11:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 10:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 8:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 5:29 p.m. Jan. 10, 2014 - Sue Chang
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update 10:34 a.m. Aug. 23, 2014 - Seeking Alpha
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside 12:01 p.m. Aug. 22, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 8/18/14 6:18 a.m. Aug. 19, 2014 - Seeking Alpha
Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News 1:00 p.m. Aug. 14, 2014 - Zacks.com
Intercept Pharmaceuticals Inc Stock Upgraded (ICPT) 11:12 a.m. Aug. 14, 2014 - TheStreet.com
Perilous Reversal Watch: Intercept Pharmaceuticals (ICPT) 9:58 a.m. Aug. 14, 2014 - TheStreet.com
Analysts' Actions: Cree, Intercept Pharma, Intermune, Tivo 7:39 a.m. Aug. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog 10:40 a.m. Aug. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Worth Watching: Stock Gains 16.6% - Tale of the Tape 9:25 a.m. Aug. 13, 2014 - Zacks.com
'Fast Money' Recap: Stick With U.S. Stocks 5:00 a.m. Aug. 13, 2014 - TheStreet.com
U.S. Stocks End Lower 5:32 p.m. Aug. 12, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Russian Sanctions and Oil in Focus 8/12/14 - Stocks in the News 3:33 p.m. Aug. 12, 2014 - Zacks.com
Intercept Pharma (ICPT) Shares Soar on Liver Disease Drug News - Stocks in the News 2:40 p.m. Aug. 12, 2014 - Zacks.com
Why Intercept Pharmaceuticals (ICPT) Stock Is Skyrocketing Today 12:54 p.m. Aug. 12, 2014 - InvestorPlace.com
Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential 12:27 p.m. Aug. 12, 2014 - Seeking Alpha
Today's Market: New, Disputes And Earnings Impacting These Names 10:55 a.m. Aug. 12, 2014 - Seeking Alpha
Jim Cramer's Mad Dash: The Fed Is Overlooking Biotech Growth 10:39 a.m. Aug. 12, 2014 - TheStreet.com
Intercept Pharma Soars On Liver-Disease Drug Data 9:48 a.m. Aug. 12, 2014 - Investors Business Daily
Why Intercept Pharmaceuticals (ICPT) Stock Is Spiking In Pre-Market Trading Today 9:05 a.m. Aug. 12, 2014 - TheStreet.com
Conatus Shares Move Higher On Industry Data 8:11 a.m. Aug. 12, 2014 - benzinga.com
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 9:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 9:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 5:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 10:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 10:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 9:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 11:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 10:21 a.m. May 13, 2014 - ACCESSWIRE
Earnings Results, Agreements, Study Results, FDA Approvals, and Drug Trial Results - Analyst Notes on Merck, Johnson & Johnson, GlaxoSmithKline, Novartis and Intercept 8:00 a.m. May 12, 2014 - PR Newswire - PRF
Intercept Reports Additional Positive OCA Data in Patients With Bile Acid Diarrhea at Digestive Disease Week 4:06 p.m. May 6, 2014 - GlobeNewswire
Intercept to Host First Quarter 2014 Update on May 7 and Present at Upcoming Investor Conferences 6:06 a.m. May 1, 2014 - GlobeNewswire
Intercept Pharmaceuticals Appoints Rachel McMinn, Ph.D. as Chief Strategy Officer 4:50 p.m. April 30, 2014 - GlobeNewswire
Stock Price Movements, Updates on Clinical Studies, Financial Results Releases, and Company Response to New Laws - Analyst Notes on Perrigo, GlaxoSmithKline, Intercept, Centene and Lorillard 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept 8:00 a.m. April 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- ICPT 4:01 a.m. April 14, 2014 - GlobeNewswire
Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session 12:00 p.m. April 12, 2014 - GlobeNewswire
Intercept Announces Preclinical Data Demonstrating OCA's Potential Role in Preventing Complications of Cirrhosis 9:04 a.m. April 11, 2014 - GlobeNewswire
UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against INTERCEPT PHARMACEUTICALS, INC. and Its Board of Directors and a Lead Plaintiff Deadline of April 22, 2014 -- ICPT 11:48 a.m. April 10, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼